BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/5/17 申報。只含多頭部位。
- 持股檔數
- 67
- 2020 年第 4 季沒有 13F 資料
- 總值
- $26.7 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| Five Prime Therapeutics Inc33830X104 | COM | 6,338,678 | $2.39 億 | 9.0% | – | – | – |
| OLMAOlema Pharmaceuticals, Inc. | COM | 6,661,503 | $2.21 億 | 8.3% | – | – | 歷史 |
| MRUSMerus N.V. | COM | 7,285,071 | $1.52 億 | 5.7% | – | – | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $1.44 億 | 5.4% | – | – | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 2,943,049 | $1.35 億 | 5.1% | – | – | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 3,722,398 | $1.14 億 | 4.3% | – | – | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,959,451 | $1.03 億 | 3.8% | – | – | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 2,630,658 | $1.02 億 | 3.8% | – | – | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 2,873,147 | $9,933 萬 | 3.7% | – | – | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 309,599 | $8,526 萬 | 3.2% | – | – | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,908,326 | $8,449 萬 | 3.2% | – | – | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 3,481,778 | $6,232 萬 | 2.3% | – | – | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,364,461 | $6,135 萬 | 2.3% | – | – | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,607,969 | $6,129 萬 | 2.3% | – | – | 歷史 |
| ACIUAC Immune SA | SHS | 7,504,579 | $5,711 萬 | 2.1% | – | – | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 1,876,122 | $5,268 萬 | 2.0% | – | – | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 8,394,000 | $4,927 萬 | 1.8% | – | – | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,635,112 | $4,623 萬 | 1.7% | – | – | 歷史 |
| IMAImageneBio, Inc. | COM | 1,599,658 | $4,519 萬 | 1.7% | – | – | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 1,031,070 | $4,473 萬 | 1.7% | – | – | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,049,356 | $4,373 萬 | 1.6% | – | – | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 5,576,471 | $4,311 萬 | 1.6% | – | – | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 2,864,299 | $3,615 萬 | 1.4% | – | – | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 2,137,978 | $3,147 萬 | 1.2% | – | – | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $2,873 萬 | 1.1% | – | – | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,094,174 | $2,862 萬 | 1.1% | – | – | 歷史 |
| VSTMVerastem, Inc. | COM | 11,480,994 | $2,836 萬 | 1.1% | – | – | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 8,383,645 | $2,708 萬 | 1.0% | – | – | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,417,551 | $2,580 萬 | 1.0% | – | – | 歷史 |
| ANABAnaptysbio, Inc | COM | 1,189,500 | $2,563 萬 | 1.0% | – | – | 歷史 |
| FBRXForte Biosciences, Inc. | COM | 718,788 | $2,463 萬 | 0.9% | – | – | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $2,072 萬 | 0.8% | – | – | – |
| CTICCti Biopharma Corp | COM | 6,929,690 | $2,017 萬 | 0.8% | – | – | 歷史 |
| STROSutro Biopharma, Inc. | COM | 826,825 | $1,882 萬 | 0.7% | – | – | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,144,016 | $1,835 萬 | 0.7% | – | – | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 3,812,300 | $1,830 萬 | 0.7% | – | – | 歷史 |
| GRTSGritstone bio, Inc. | COM | 1,861,239 | $1,755 萬 | 0.7% | – | – | 歷史 |
| SLNSilence Therapeutics plc | ADS | 666,666 | $1,582 萬 | 0.6% | – | – | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 875,000 | $1,581 萬 | 0.6% | – | – | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,494,582 | $1,412 萬 | 0.5% | – | – | – |
| REPLReplimune Group, Inc. | COM | 461,428 | $1,408 萬 | 0.5% | – | – | 歷史 |
| CALACalithera Biosciences, Inc. | COM | 5,566,690 | $1,347 萬 | 0.5% | – | – | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $1,345 萬 | 0.5% | – | – | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,588,155 | $1,231 萬 | 0.5% | – | – | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,113,435 | $1,191 萬 | 0.4% | – | – | 歷史 |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $1,087 萬 | 0.4% | – | – | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 2,379,986 | $1,077 萬 | 0.4% | – | – | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 1,715,981 | $1,066 萬 | 0.4% | – | – | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 3,739,704 | $994.8 萬 | 0.4% | – | – | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 3,229,426 | $994.7 萬 | 0.4% | – | – | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 1,091,579 | $939.8 萬 | 0.4% | – | – | 歷史 |
| BCTG Acquisition Corp05492W103 | COM | 800,000 | $889.6 萬 | 0.3% | – | – | – |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 772,226 | $811.6 萬 | 0.3% | – | – | – |
| VRDNViridian Therapeutics, Inc. | COM | 463,504 | $774.5 萬 | 0.3% | – | – | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $753.0 萬 | 0.3% | – | – | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $617.3 萬 | 0.2% | – | – | 歷史 |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $512.5 萬 | 0.2% | – | – | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $510.5 萬 | 0.2% | – | – | – |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $503.0 萬 | 0.2% | – | – | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $497.5 萬 | 0.2% | – | – | – |
| Erytech Pharma29604W108 | SPONSORED ADR | 625,000 | $446.9 萬 | 0.2% | – | – | – |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 647,299 | $443.4 萬 | 0.2% | – | – | – |
| SNDXSyndax Pharmaceuticals Inc | COM | 163,524 | $365.6 萬 | 0.1% | – | – | 歷史 |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $295.2 萬 | 0.1% | – | – | 歷史 |
| IVAInventiva S.A. | ADS | 107,000 | $157.3 萬 | 0.1% | – | – | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $134.7 萬 | 0.1% | – | – | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 100,000 | $101.4 萬 | <0.1% | – | – | 歷史 |